Messenger RNA analysis

Break through barriers and extend the frontiers of messenger RNA (mRNA), self-amplifying RNA (saRNA) and circular RNA (circRNA) development with intuitive analytical solutions. Confidently innovate with high-quality, sensitive and accurate data to assess integrity, purity and critical quality attributes (CQAs).

Request info

Overview

The analysis of mRNA is complex due to its fragile nature, heterogeneity and length. 

Discover workflows that let you break through the analytical boundaries of in vitro transcribed (IVT) products and provide quality results to confidently address the challenges of mRNA, circRNA and saRNA development. 

Determine CQAs, integrity, purity and secondary structures with intuitive solutions that provide meaningful answers to keep your process in progress.

Workflow

mRNA integrity and purity

mRNA product quality is directly linked to integrity and purity. 

Enable control of your RNA products. Assess the purity of full-sized mRNA molecules with the highest quality and resolution, and create pathways for analyzing and understanding these fragile molecules more easily and reliably. 

Kit-based solutions let you save time so you can focus on your research and help determine the future of medicine.

  • Achieve high-resolution mRNA and impurity separation over an extended size range 
  • Precise kit solutions with pre-assembled cartridges deliver superior accuracy and precision
  • Find relevant impurities (even below 1%) with laser-induced fluorescence (LIF) detection 
  • Cover your compliance needs through compatibility with the Empower Chromatography Data System (CDS)
0
to cover the widest range

mRNA integrity and purity

Solution

Suited for:
  • High-quality separation
  • Accelerated method development and mRNA sample analysis
Request info
Request info

Featured resources

Filter:
Assessment of integrity and purity of mRNAs from LNPs

Take control of impurities and artifacts in your mRNA-lipid nanoparticle (LNP) products. Achieve high-quality, robust assessment of the integrity and size of mRNA molecules encapsulated in LNPs.

Assessment of distinct mRNA-LNP formulations by CGE-LIF and implications for RNA-based drugs

Learn from scientist Jérémie Parot (SINTEF) how to break through the boundaries of mRNA analysis.

Empowering next-generation therapy development with streamlined data integration

Discover how to save time by streamlining your CE data management with the Empower CDS.

Compliant-ready, streamlined data management for mRNA analyses with Empower CDS

Set your own schedule for mRNA analyses by streamlining your CE data management with the Empower CDS.

mRNA integrity and purity

Solution

Suited for:
  • High-quality separation
  • Low to medium throughput needs
Request info
Request info

Featured resource

Comprehensive method development for a wide size range of single-stranded nucleic acids

Create pathways for effective method development and learn how to achieve the highest quality data for RNA products with sizes ranging from 50–9,000 nucleotides and beyond.

Workflow

CircRNA

The use of next-generation RNA, such as circular RNA (circRNA)—a type of RNA that is not dependent on CQAs such as 3' poly-A tails or 5' capping—is growing. 

Pursue improved RNA-based drugs with the ability to confidently separate circRNA from linear precursors and assess a continuous loop of RNA using high-quality data.

  • Take control of your circRNA purity with a %CV of <2%
  • Rely on superior separation of impurities with highly sensitive detection
  • Save time with automated size determination and quantitation of linear RNA precursors
  • Cover your compliance needs through compatibility with the Empower CDS
0
of magnitude detection range
0
for purity assessment

CircRNA

Solution

Suited for:
  • High-quality separation
  • Accelerated method development and mRNA sample analysis
Request info
Request info

Featured resource

Separation of circular RNA from its linear precursor

Pave the way to better characterization of circRNA generated from linear precursors and take your RNA analysis to the next level.

CircRNA

Solution

Suited for:
  • High-quality separation
  • Low to medium throughput needs
Request info
Request info

Workflow

5’ capping

Imagine taking control of your mRNA stability and translation efficiency by better understanding your 5’ CQAs. 

Characterize and quantify capped vs. uncapped mRNA species and dig deeper into distinguishing different capping intermediates with high-quality data generated using solutions based on capillary electrophoresis (CE) and accurate mass spectrometry.

  • Clearly identify capping intermediates (G cap, cap 0 and cap 1) with accurate mass information
  • Break free from quantitation limitations with accurate mass quantitation 
  • Differentiate capped from uncapped 5’ ends with high-quality CE solutions
  • Be prepared for a method transfer to quality control (QC) with reliable CE solutions

5’ capping

Solution

Suited for:
  • Identification and quantitation of 5'-end capping intermediates
  • Robust, analytical flow setup
Request info
Request info

5’ capping

Solution

Suited for:
  • Identification and highly sensitive quantitation of capping intermediates
  • Meeting flexibility needs to perform a range of additional workflows
Request info
Request info

5’ capping

Solution

Suited for:
  • Differentiation of capped from non-capped 5' ends
  • Assay transfer to quality control (QC)
Request info
Request info

Workflow

3’ poly-A tail

Understanding product stability lays the foundation for improved drugs. 

Lead the way by characterizing your 3’-end CQAs, whether you are using template-encoded tails, enzymatic addition or a combination of these approaches. 

Give your team the power to determine the lengths of the adenosine tails and their distribution profiles in mature mRNA products with solutions based on CE and accurate mass systems.

  • Progress your mRNA development with a clear understanding of your poly-A tails
  • Access poly-A tail length information via deconvolution of high-quality accurate mass data
  • Obtain size information for 3’ tails with excellent base resolution via CE

3’ poly-A tail

Solution

Suited for:
  • Molecular weight determination of 3'-end poly-A tails
  • Robust, analytical flow setup
Request info
Request info

3’ poly-A tail

Solution

Suited for:
  • Molecular weight determination of 3'-end poly-A tails
  • Meeting flexibility needs to perform a range of additional workflows
Request info
Request info

3’ poly-A tail

Solution

Suited for:
  • Achieving the highest resolution power
  • QC deployment
Request info
Request info

Workflow

Secondary structure

RNA structures can affect your LNP formulations and the stability and efficacy of a final product. Gain greater control of structural prediction for your oligonucleotides of interest. Leverage solutions that gather empirical data without nucleotide or structural bias to enable better insights into RNA backbone flexibility based on base-paired and unconstrained residues.

  • Achieve structural understanding with data-driven information
  • Find hotspots for backbone flexibility in your nucleic acid products
  • Benefit from data without nucleotide bias

Secondary structure

Solution

Featured resource

Understanding secondary structures of single-stranded RNA with chemical probing

Breeze into achieving stable encapsulation of RNA molecules in LNPs. Be empowered to make informed decisions with structural data on your modalities.

All resources

Filter:
Development of better LNP-based genetic medicines

Break through the barriers to developing better LNP-based drugs and make better use of your time with streamlined CE and MS workflows for mRNA-LNPs.

Beyond mRNA: how advances in analytical techniques are revolutionizing the RNA drug landscape

Self-amplifying RNA (saRNA) can enable lower dosing and expand the range of potential indications. However, srRNAs are often much larger in size (>9,000 bases). Learn how to assess these large molecules with high-resolution assays.

Assessment of integrity and purity of mRNAs from LNPs

Take control of impurities and artifacts in your mRNA-lipid nanoparticle (LNP) products. Achieve high-quality, robust assessment of the integrity and size of mRNA molecules encapsulated in LNPs.

Assessment of distinct mRNA-LNP formulations by CGE-LIF and implications for RNA-based drugs

Learn from scientist Jérémie Parot (SINTEF) how to break through the boundaries of mRNA analysis.

Empowering next-generation therapy development with streamlined data integration

Discover how to save time by streamlining your CE data management with the Empower CDS.

Compliant-ready, streamlined data management for mRNA analyses with Empower CDS

Set your own schedule for mRNA analyses by streamlining your CE data management with the Empower CDS.

Comprehensive method development for a wide size range of single-stranded nucleic acids

Create pathways for effective method development and learn how to achieve the highest quality data for RNA products with sizes ranging from 50–9,000 nucleotides and beyond.

Separation of circular RNA from its linear precursor

Pave the way to better characterization of circRNA generated from linear precursors and take your RNA analysis to the next level.

Understanding secondary structures of single-stranded RNA with chemical probing

Breeze into achieving stable encapsulation of RNA molecules in lipid nanoparticles (LNPs). Be empowered to make informed decisions with structural data on your modalities.

Contact SCIEX
Don't see a solution that works for you? Request more information to understand how our products can fit your needs.